No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma

byTeddy Guo

April 5, 2023

in StudyGraphics

Reading Time: 1 min read

Antidepressants may improve symptoms in patients with inflammatory bowel disease

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

February 19, 2026

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Cardiac arrest survival during delivery lowest in those with disseminated intravascular coagulation

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail

Incongruency between patients’ values and comfort-focused care on maintenance dialysis

The American Heart Association's Life Essential 8 scores to predict cardiovascular health

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports